1. Home
  2. ANIX vs SDA Comparison

ANIX vs SDA Comparison

Compare ANIX & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

SDA

SunCar Technology Group Inc.

HOLD

Current Price

$0.78

Market Cap

71.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
SDA
Founded
1982
2007
Country
United States
China
Employees
N/A
544
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
71.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ANIX
SDA
Price
$2.74
$0.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$8.67
$4.75
AVG Volume (30 Days)
158.6K
1.4M
Earning Date
05-27-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
$12.01
Revenue Next Year
N/A
$15.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$0.47
52 Week High
$5.46
$2.93

Technical Indicators

Market Signals
Indicator
ANIX
SDA
Relative Strength Index (RSI) 51.99 41.70
Support Level $2.38 $0.72
Resistance Level $3.12 $2.18
Average True Range (ATR) 0.19 0.13
MACD 0.04 -0.01
Stochastic Oscillator 61.54 9.36

Price Performance

Historical Comparison
ANIX
SDA

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.

Share on Social Networks: